| Literature DB >> 26573214 |
Amir Klein1, Nicholas Tutticci1, Michael J Bourke1,2.
Abstract
Historically, neoplasia of the duodenal papilla has been managed surgically, which may be associated with substantial morbidity and mortality. In the absence of invasive cancer, even lesions with extensive lateral duodenal wall involvement, or limited intraductal extension may be cured endoscopically with a superior safety profile. Endoscopic papillectomy is associated with greater risks of adverse events such as bleeding than resection elsewhere in the gastrointestinal tract. Additionally site-specific complications such as pancreatitis exist. A structured approach to lesion assessment, adherence to technical aspects of resection, endoscopic management of complications and post-resection surveillance is required. Advances have been made in all facets of endoscopic papillary resection since its introduction in the 1980s; extending the boundaries of endoscopic cure, optimizing outcomes and enhancing patient safety. These will be the focus of the present review.Entities:
Keywords: ampullary adenoma; ampullectomy; endoscopic mucosal resection; papillectomy
Mesh:
Year: 2015 PMID: 26573214 DOI: 10.1111/den.12574
Source DB: PubMed Journal: Dig Endosc ISSN: 0915-5635 Impact factor: 7.559